Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 138, Issue -, Pages 233-240Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2019.03.010
Keywords
Oncofertility; Female cancer patients; Fertility preservation; Expert recommendations; Oncologists; Haematologists
Categories
Funding
- Theramex HQ UK Limited
- Teva/Theramex
Ask authors/readers for more resources
In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available